These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7412431)

  • 1. [Cooperative study of bacterial incidence and susceptibility to cefamandole and other antibiotics (author's transl)].
    de Vega JC; Pais JR; del Tánago AG
    Med Clin (Barc); 1980 May; 74(10):387-94. PubMed ID: 7412431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre study of the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicin.
    du T Naudé W; van den Ende J; Botha P; Forder A; Hyland J; de Klerk HC; Neiteler BF; Koornhof HJ; Robinson R; Robins-Browne R; Block C; Appelbaum PC; Africa CW; van Rensburg AJ; Jooste PJ; Crewe-Browne H; Fernandez A
    S Afr Med J; 1977 Nov; 52(20):798-800. PubMed ID: 305120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
    Brorson JE; Norrby R
    Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
    [No Abstract]   [Full Text] [Related]  

  • 5. [In vitro and in vivo antimicrobial activity of cefuroxime cefamandole and cephalexin on freshly isolated strains of Gram-positive and Gram-negative bacteria].
    Piccolomini R; Arpini A; Di Sipio L; Minelli G
    Boll Soc Ital Biol Sper; 1981 Jul; 57(13):1450-6. PubMed ID: 7284112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compared sensitivities of 532 bacterial strains to six cephalosporins.
    Courtieu AL; Drugeon H
    Int J Clin Pharmacol Res; 1983; 3(3):195-201. PubMed ID: 6679522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of new cephalosporins against polyresistant bacterial strains].
    De Toffoli A; Fantin B
    Minerva Med; 1983 Mar; 74(9-10):427-31. PubMed ID: 6300736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of cefamandole against enterobacteria resistant to cephalosporins (author's transl)].
    Kazmierczak A; Gailliard MC; Portier H; Siebor E; Labia R
    Nouv Presse Med; 1979 Oct; 8(39):3157-60. PubMed ID: 261332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro activity of cefamandole against 3312 bacterial isolates. A Norwegian multicentre study.
    Digranes A; Bjorvatn B
    NIPH Ann; 1980 Dec; 3(2):141-7. PubMed ID: 7219840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro testing of newer cephalosporins (author's transl)].
    Linzenmeier G; Rosenthal E
    Infection; 1979; 7 Suppl 2():S225-7. PubMed ID: 437897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefonicid, a long acting cephalosporin: in vitro activity compared with three cephalosporins and gentamicin.
    Hamilton-Miller JM; Patel R; Brumfitt W
    Drugs Exp Clin Res; 1986; 12(11):861-9. PubMed ID: 3816503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cefamandole: in vitro and in vivo activity].
    Martinetto P; Valtz A; Cavallo GP; Angeretti A
    G Batteriol Virol Immunol; 1979; 72(1-6):44-61. PubMed ID: 553842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro susceptibility of Listeria monocytogenes with special reference to newer beta lactam antibiotics (author's transl)].
    Marklein G; Häfelein J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(1):40-53. PubMed ID: 6277101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of cephamandole against some gram-negative bacilli and staphylococci.
    Dzierzanowska D; Jakubicz P; Niedźwiecka M; Borowski J
    Arch Immunol Ther Exp (Warsz); 1980; 28(3):389-91. PubMed ID: 6969585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.
    Rosenthal SL; Freundlich LF; Quraishi MA
    Chemotherapy; 1979; 25(3):157-61. PubMed ID: 456076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1973 Jun; 3(6):657-61. PubMed ID: 4790616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefamandole resistance transfer in bacterial strains from two newborn units.
    Krcméry V; Antal M; Havlík J; Knothe H
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(4):409-15. PubMed ID: 3910723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.